{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T05:26:31Z","timestamp":1697088391630},"reference-count":28,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,1,10]],"date-time":"2005-01-10T00:00:00Z","timestamp":1105315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Pathology Medicine"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> There are no reliably effective therapies for oral lichen planus (OLP). The aim of the present work was to determine the potential efficacy of oxpentifylline in the management of OLP.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Fifteen patients (six males, median age for the group 52\u2003years, ranging from 33 to 72) with clinically and histopathologically confirmed OLP were treated with oxpentifylline at a dose of 400\u2003mg three times daily.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Only 10 patients completed an 8\u2003week course, the other five having to stop therapy because of adverse effects. Only three patients had any relief of their signs and symptoms of OLP.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> The results indicate that oxpentifylline is unlikely to be of benefit for the treatment of OLP.<\/jats:p>","DOI":"10.1111\/j.1600-0714.2004.00278.x","type":"journal-article","created":{"date-parts":[[2005,1,10]],"date-time":"2005-01-10T10:03:10Z","timestamp":1105351390000},"page":"106-108","source":"Crossref","is-referenced-by-count":3,"title":["Oxpentifylline is not effective for symptomatic oral lichen planus"],"prefix":"10.1111","volume":"34","author":[{"given":"Sasiwong","family":"Wongwatana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jair C.","family":"Leao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crispian","family":"Scully","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,10]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/10454411980090010501"},{"key":"e_1_2_8_3_2","first-page":"CD001168","article-title":"Interventions for treating oral lichen planus","volume":"2","author":"Chan ES","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1079-2104(96)80198-3"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155501317140197"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.10.1335"},{"key":"e_1_2_8_7_2","first-page":"466","article-title":"Long\u2010term efficacy and safety of topical tacrolimus in the management of ulcerative\/erosive oral lichen planus","volume":"13","author":"Hodgson TA","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119648"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2003001000011"},{"key":"e_1_2_8_10_2","first-page":"625","article-title":"An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis","volume":"22","author":"Maksymowych WP","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92635-6"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-10-199605150-00005"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_120"},{"key":"e_1_2_8_14_2","first-page":"97","article-title":"Use of pentoxifylline in the treatment of systemic scleroderma","volume":"1","author":"Neiko I","year":"2002","journal-title":"Lik Sprava"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.124.4.1526"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02728.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2340\/00015555767980","article-title":"Recurrent aphthous stomatitis: treatment with pentoxifylline","volume":"76","author":"Pizarro A","year":"1996","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91310-6"},{"key":"e_1_2_8_19_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2340\/0001555575157","article-title":"Severe idiopathic recurrent aphthous stomatitis: treatment with pentoxifylline","volume":"75","author":"Wahba\u2010Yahav AV.","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70313-X"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/154411130201300405"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198734010-00003"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202X.2003.22108.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000074116"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1368-8375(01)00114-2"},{"key":"e_1_2_8_26_2","first-page":"1109","article-title":"Treatment of erosive oral lichen planus with thalidomide","volume":"130","author":"Macario\u2010Barrel A","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000018244"},{"key":"e_1_2_8_28_2","article-title":"Severe oral epithelial dysplasia following adalimumab therapy","author":"Leao JC","year":"2004","journal-title":"Rheumatology"},{"key":"e_1_2_8_29_2","first-page":"311","article-title":"Treatment of Schamberg's disease with pentoxifylline","volume":"69","author":"Panda S.","year":"2003","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2004.00278.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0714.2004.00278.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T13:19:08Z","timestamp":1697030348000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2004.00278.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,10]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1600-0714.2004.00278.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2004.00278.x","archive":["Portico"],"relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,10]]}}}